Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Dispatch

Hospitalization and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002

Jay K. Varma*Comments to Author , Katherine D. Greene*, Jessa Ovitt†, Timothy J. Barrett*, Felicita Medalla*, and Frederick J. Angulo*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, GA, USA; †Private practice, Lenoir, NC, USA

Main Article

Table

Hospitalization and death rates among nontyphoidal Salmonella outbreaks by resistance pattern, 1984–2002*

Resistance pattern Outbreaks
Patients
n (median % [range]) p value No./total (%) p value
Hospitalization
Pansusceptible 22 (9.7 [0–37.5]) Referent 164/2,194 (7.5) Referent
Resistant >1 10 (26.2 [9.3–49.3]) <0.01 2,913/13,286 (21.9) <0.01
R-type AC/KSSuT 7 (26.1 [9.3–48.9]) 0.02 2,827/12,806 (22.1) <0.01
Clinically important agent 9 (26.1 [9.3–48.9]) 0.04 2,877/13,213 (21.8) <0.01
Death
Pansusceptible 16 (0 [0–0.6]) Referent 2/3,283 (0.06) Referent
Resistant >1 8 (0.1 [0–1.4]) 0.05 23/18,644 (0.1) 0.57
R-type AC/KSSuT 5 (0 [0–0.7]) 0.21 20/17,150 (0.1) 0.56
Clinically important agent 6 (0 [0–0.7]) 0.69 20/17,865 (0.1) 0.80

*AC/KSSut, ampicillin, chloramphenicol, kanamycin, streptomycin, sulfamethoxazole, tetracycline.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external